Solvias announced the acquisition of Confarma, headquartered in Münchenstein, and its subsidiary Confarma France.

Solvias, a pharmaceutical service provider, is pursuing a long-term growth strategy with the aim of expanding its extensive range of services for pharmaceutical companies. By acquiring the Confarma Group, Solvias and Confarma are increasing the range of analytical services they can offer their partners in pharmaceuticals, biotechnology, and life science.